Strategic Support at Every Stage of Litigation
Whether you're building your case or preparing for trial, we serve as a strategic partner throughout the legal process:
- Early Case Assessment: We help legal teams evaluate regulatory strengths and weaknesses and refine case strategy
- Expert Reports & Declarations: Our experts craft detailed, objective reports that withstand scrutiny and communicate clearly
- Deposition & Trial Testimony: Our seasoned experts are skilled at delivering confident, credible testimony that holds up under cross-examination
- Rebuttal & Opposing Expert Analysis: We review and critique the opinions and assumptions of opposing FDA experts to help you anticipate challenges and build counterpoints
From technical assessments to high-stakes testimony, ProPharma’s expert witness consultants deliver the insight and authority your case needs.
Who We Serve
Our FDA expert witness services are trusted by top-tier clients around the world, including:
- Law Firms representing pharmaceutical, medical device, biotechnology, and diagnostics companies in civil, criminal, and regulatory matters
- Life Sciences Companies facing litigation, government investigations, product recalls, or shareholder actions
- Insurance Providers & Risk Managers seeking defensible analysis of regulatory compliance and product safety claims
- Litigation Support Firms in need of high-caliber expert evaluation, documentation review, and testimony
When regulatory credibility is on the line, leading firms rely on our unparalleled FDA knowledge and litigation support capabilities.
News & Insights
August 4, 2025
European Marketing Authorization Success: The Critical Role of Quality and Compl...
Achieve European market success with robust quality and compliance solutions, ensuring seamless market entry and long-term growth through expert QP support
July 31, 2025
Pros and Cons of Working with a CRO
Explore the pros and cons of working with a Contract Research Organization (CRO) and how ProPharma sets a new standard in clinical development success.
July 28, 2025
Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market
Learn about PADER, a crucial pharmacovigilance requirement for U.S. drug safety monitoring, and how it differs from PSUR in ensuring compliance and patient safety. Summarizing the main point of the...
.png?width=320&height=185&name=Obesity%20%E2%80%93%20Accelerated%20Timelines%20(1).png)
.png?width=320&height=185&name=labeling-webinar-thumbnail%20(1).png)
News & Insights
July 8, 2025
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 21, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
